Maternal exposure to prescription and non-prescription pharmaceuticals or drugs of abuse and risk of craniosynostosis.
about
A genome-wide association study identifies susceptibility loci for nonsyndromic sagittal craniosynostosis near BMP2 and within BBS9Unravelling the molecular control of calvarial suture fusion in children with craniosynostosis.Retinoic acid enhances osteogenesis in cranial suture-derived mesenchymal cells: potential mechanisms of retinoid-induced craniosynostosisFamilial incidence and associated symptoms in a population of individuals with nonsyndromic craniosynostosisUpdate on new developments in the study of human teratogens.Prevalence and patterns of nitrosatable drug use among U.S. women during early pregnancyNitrosatable drug exposure during the first trimester of pregnancy and selected congenital malformations.Role of Old Antibiotics in the Era of Antibiotic Resistance. Highlighted Nitrofurantoin for the Treatment of Lower Urinary Tract InfectionsGene expression profiling in human craniosynostoses: a tool to investigate the molecular basis of suture ossification.Isolated sagittal craniosynostosis: definition, classification, and surgical indications.Impact of Periconceptional Use of Nitrosatable Drugs on the Risk of Neural Tube Defects.Nitrofurantoin and pregnancy.Proteomic comparison of human and great ape blood plasma reveals conserved glycosylation and differences in thyroid hormone metabolism.Exposure to nitrofurantoin during the first trimester of pregnancy and the risk for major malformations.
P2860
Q28943389-B6EB6EAA-21D8-42E6-A633-22D86C3EB5F9Q33310098-91DFA9DD-9075-447D-8F90-0DF550F62F5EQ34018035-2172EDF1-BAA9-4A58-9BF4-4124FAE95CFBQ34086690-DBFE4DEF-12DD-43C5-89BD-C8A76F0389BCQ34123327-55D1AC6E-68F0-433A-9E39-76588C2107B9Q35023144-4623A38A-4CEB-4844-9C94-343F3BA99ED3Q36369451-8CF52FBD-21C3-4356-883A-7986FCFE5549Q36683599-A675CF4A-5291-4D1F-B86B-517DEADB657BQ38032763-F82F1BD3-3A78-4818-8DBE-42EA97F672CAQ38032765-42F9D6CD-6BAD-4903-8F6C-C0BDFB7E27E2Q40480654-446C05C9-211D-4A06-8804-B77054677829Q42747979-6768BC12-62C0-4AFC-8182-919321353318Q44214643-F3C0C5B6-FCB0-4A91-B42F-4896E9CE48C5Q47826642-8A55C991-ABBD-4E76-BC1F-AD9730AE6000
P2860
Maternal exposure to prescription and non-prescription pharmaceuticals or drugs of abuse and risk of craniosynostosis.
description
1998 nî lūn-bûn
@nan
1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Maternal exposure to prescript ...... and risk of craniosynostosis.
@ast
Maternal exposure to prescript ...... and risk of craniosynostosis.
@en
Maternal exposure to prescript ...... and risk of craniosynostosis.
@nl
type
label
Maternal exposure to prescript ...... and risk of craniosynostosis.
@ast
Maternal exposure to prescript ...... and risk of craniosynostosis.
@en
Maternal exposure to prescript ...... and risk of craniosynostosis.
@nl
prefLabel
Maternal exposure to prescript ...... and risk of craniosynostosis.
@ast
Maternal exposure to prescript ...... and risk of craniosynostosis.
@en
Maternal exposure to prescript ...... and risk of craniosynostosis.
@nl
P2093
P356
P1476
Maternal exposure to prescript ...... and risk of craniosynostosis.
@en
P2093
Alderman BW
Fernbach SK
Gardner JS
Guyard-Boileau B
Mangione EJ
P356
10.1093/IJE/27.1.64
P577
1998-02-01T00:00:00Z